Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gaia Rachele Oliva
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0000-5911-3390
Observed ORCID:
0009-0000-5911-3390
OpenAlex ID:
A5108880858
Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response
2024
·
Pierluigi De Santis
, Martina Perrone
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
22
PDF
Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?
2023
·
Pierluigi De Santis
, Valeria Sanna
, et al.
·
Journal of Clinical Medicine
·
8
PDF
Bone Health and Endocrine Therapy with Ovarian Function Suppression in Premenopausal Early Breast Cancer: A Real-Life Monocenter Experience with Denosumab
2025
·
Angelachiara Rotondi
, Valentina Frescura
, et al.
·
Current Oncology
·
4
PDF
Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors
2026
·
Ilaria Poli
, Gaia Rachele Oliva
, et al.
·
Journal of Personalized Medicine
·
2
PDF
Circulating tumor DNA in breast cancer in 2027: advancing liquid biopsy and molecular monitoring
2026
·
Gaia Rachele Oliva
, Massimo Cristofanilli
, et al.
·
Current Opinion in Obstetrics & Gynecology
Metastatic Giant Cell Bladder Variant of Urothelial Carcinoma: Description of a rare Case Report successfully treated by a 3 rd line chemotherapy with weekly paclitaxel
2025
·
Gaia Rachele Oliva
, Davide Leo
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
6
Citation count:
36
H-index:
3
I10-index:
1
Year
Topic
Type